Safety and efficacy of pyrazine derivatives including saturated ones belonging to chemical group 24 when used as flavourings for all animal species by G. Rychen et al.
SCIENTIFIC OUTPUT
ADOPTED: 6 December 2016
doi: 10.2903/j.efsa.2017.4671
Safety and efﬁcacy of pyrazine derivatives including
saturated ones belonging to chemical group 24 when used
as ﬂavourings for all animal species
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP),
Guido Rychen, Gabriele Aquilina, Giovanna Azimonti, Vasileios Bampidis,
Maria de Lourdes Bastos, Georges Bories, Pier Sandro Cocconcelli, Gerhard Flachowsky,
J€urgen Gropp, Boris Kolar, Maryline Kouba, Secundino Lopez Puente, Marta Lopez-Alonso,
Alberto Mantovani, Baltasar Mayo, Fernando Ramos, Maria Saarela, Roberto Edoardo Villa,
Robert John Wallace, Pieter Wester, Paul Brantom, Birgit Dusemund, Christer Hogstrand,
Patrick Van Beelen, Johannes Westendorf, Lucilla Gregoretti, Paola Manini and Andrew Chesson
Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of 22 compounds belonging to chemical group 24 (pyrazine derivatives). They are currently
authorised as ﬂavours in food. The FEEDAP Panel concludes that: 2,3-diethylpyrazine [14.005], 2-ethyl-3-
methylpyrazine [14.006], 5,6,7,8-tetrahydroquinoxaline [14.015], 2,3,5,6-tetramethylpyrazine [14.018],
2,3,5-trimethylpyrazine [14.019], 2,5-dimethylpyrazine [14.020], 2,6-dimethylpyrazine [14.021], 2-
ethylpyrazine [14.022], 2-ethyl-3,5-dimethylpyrazine [14.024], 2,5 or 6-methoxy-3-methylpyrazine
[14.025], 2-methylpyrazine [14.027], acetylpyrazine [14.032], 6,7-dihydro-5-methyl-5H-cyclopenta(b)
pyrazine [14.037], 2-isobutyl-3-methoxypyrazine [14.043], 2-acetyl-3-ethylpyrazine [14.049], 2,3-
dimethylpyrazine [14.050], 2,3-diethyl-5-methylpyrazine [14.056], 2-(sec-butyl)-3-methoxypyrazine
[14.062], 3,(5- or 6-)-dimethyl-2-ethylpyrazine [14.100], 2-ethyl-3-methoxypyrazine [14.112] and 2-
methoxy-3-methylpyrazine [14.126] are safe at the proposed maximum dose level (0.5 mg/kg complete
feed) as feed for cattle, salmonids and non-food-producing animals, and at the proposed normal use level
of 0.1 mg/kg complete feed for pigs and poultry; 5-methylquinoxaline [14.028] are safe only at
concentrations below the proposed use levels (0.08 mg/kg complete feed for cattle, salmonids and non-
food-producing animals, and 0.05 mg/kg complete feed for pigs and poultry). No safety concern would
arise for the consumer from the use of these compounds up to the highest proposed level in feeds.
Hazards for skin and eye contact, and respiratory exposure are recognised for the majority of the
compounds under application. Most are classiﬁed as irritating to the respiratory system. The proposed
maximum use levels in feed are unlikely to have detrimental effects on the terrestrial and fresh water
compartments. Because all the compounds under assessment are used in food as ﬂavourings and their
function in feed is essentially the same as that in food, no further demonstration of efﬁcacy is necessary.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7 and in addition, Article 10(2) of that Regulation also speciﬁes
that for existing products within the meaning of Article 10(1), an application shall be submitted in
accordance with Article 7, within a maximum of 7 years after the entry into force of this Regulation.
The European Commission received a request from Feed Flavourings Authorisation Consortium
European Economic Interest Grouping (FFAC EEIG)2 for authorisation of 22 substances belonging to
chemical group (CG) 24 (2,3-diethylpyrazine, 2-ethyl-3-methylpyrazine, 5,6,7,8-tetrahydroquinoxaline,
2,3,5,6-tetramethylpyrazine, 2,3,5-trimethylpyrazine, 2,5-dimethylpyrazine, 2,6-dimethylpyrazine,
2-ethylpyrazine, 2-ethyl-3,5-dimethylpyrazine, 2,5 or 6-methoxy-3-methylpyrazine, 2-methylpyrazine,
5-methylquinoxaline, acetylpyrazine, 5H-5-methyl-6,7-dihydrocyclopenta(b)pyrazine (herein referred to
as 6,7-dihydro-5-methyl-5H-cyclopenta(b)pyrazine), 2-isobutyl-3-methoxypyrazine, 2-acetyl-3-ethylpyrazine,
2,3-dimethylpyrazine, diethyl-5-methylpyrazine (herein referred to as 2,3-diethyl-5-methylpyrazine),
2-(sec-butyl)-3-methoxypyrazine, 2-ethyl-3,(5or6)dimethylpyrazine (herein referred to as 3,(5 or 6)-2-
ethyl-dimethylpyrazine), 2-ethyl-3-methoxypyrazine, 2-methoxy-3-methylpyrazine), when used as
feed additives for all animal species (category: sensory additives; functional group: ﬂavourings). CG
24 for ﬂavouring substances is deﬁned in Commission Regulation (EC) No 1565/20003 as ‘Pyrazine
derivatives’.
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation
of an authorised feed additive). During the course of the assessment, the applicant withdrew the
application for the use of chemically deﬁned ﬂavourings in water for drinking.4 EFSA received directly
from the applicant the technical dossier in support of this application. The particulars and documents
in support of the application were considered valid by EFSA as of 10 September 2010.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA after verifying the particulars and
documents submitted by the applicant shall undertake an assessment in order to determine whether the
feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety
for the target animals, consumer, user and the environment, and on the efﬁcacy of 2,3-diethylpyrazine
[The EU Flavour Information System (FLAVIS) Number 14.005], 2-ethyl-3-methylpyrazine [14.006], 5,6,7,
8-tetrahydroquinoxaline [14.015], 2,3,5,6-tetramethylpyrazine [14.018], 2,3,5-trimethylpyrazine [14.019],
2,5-dimethylpyrazine [14.020], 2,6-dimethylpyrazine [14.021], 2-ethylpyrazine [14.022], 2-ethyl-3,
5-dimethylpyrazine [14.024], 2,5 or 6-methoxy-3-methylpyrazine [14.025], 2-methylpyrazine [14.027],
5-methylquinoxaline [14.028], acetylpyrazine [14.032], 6,7-dihydro-5-methyl-5H-cyclopenta(b)pyrazine
[14.037], 2-isobutyl-3-methoxypyrazine [14.043], 2-acetyl-3-ethylpyrazine [14.049], 2,3-dimethylpyrazine
[14.050], 2,3-diethyl-5-methylpyrazine [14.056], 2-(sec-butyl)-3-methoxypyrazine [14.062], 3,(5- or 6-)-
dimethyl-2-ethylpyrazine [14.100], 2-ethyl-3-methoxypyrazine [14.112], 2-methoxy-3-methylpyrazine
[14.126] when used under the proposed conditions of use (see Section 3.1.3).
1.2. Additional information
All 22 substances except 2-ethyl-3-methoxypyrazine [14.112] and 2-methoxy-3-methylpyrazine
[14.126] have been assessed by the Joint Food and Agriculture Organization of the United Nations
(FAO)/World Health Organization (WHO) Expert Committee on Food Additives (JECFA; WHO, 2002a,b)
and were considered safe for use in food. No acceptable daily intake (ADI) values were established.
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 On 13/03/2013, EFSA was informed by the applicant that FFAC EEIG was liquidated on 19/12/2012 and their rights as
applicant were transferred to FEFANA asbl (EU Association of Specialty Feed Ingredients and their Mixtures). Avenue Louise
130A, Box 1, 1050 Brussels, Belgium.
3 Commission Regulation (EC) No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an
evaluation programme in application of Regulation (EC) No 2232/96 of the European Parliament and of the Council. OJ L 180,
19.7.2000, p. 8.
4 On 10 March 2016, EFSA was informed by the European Commission on the withdrawal of the application for re-authorisation
of chemically deﬁned ﬂavourings - use in water.
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Subsequently, the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
(CEF) assessed all compounds and concluded that they do not give rise to safety concerns when used
as ﬂavour in food (EFSA 2008a, EFSA CEF Panel, 2011a).
All 22 compounds are all currently listed in the European Union (EU) database of ﬂavouring
substances5 and in the EU Register of Feed Additives, and thus authorised for use in food and feed in
the EU. They have not been previously assessed by EFSA as feed additives.
Regulation (EC) No 429/20086 allows substances already approved for use in human food to be
assessed with a more limited procedure than for other feed additives. However, the use of this
procedure is always subject to the condition that food safety assessment is relevant to the use in feed.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier7 in support of the authorisation request for the use of the compounds belonging to CG 24 as
feed additives. The technical dossier was prepared following the provisions of Article 7 of Regulation
(EC) No 1831/2003, Regulation (EC) No 429/2008 and the applicable EFSA guidance documents.
The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has sought
to use the data provided by the applicant together with data from other sources, such as previous risk
assessments by EFSA or other expert bodies, peer-reviewed scientiﬁc papers and experts’ knowledge,
to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of ﬂavourings of the ‘pyrazine derivatives’ in animal feed. The Executive
Summary of the EURL report can be found in Annex A.8
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of pyrazine
derivatives is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant
guidance documents: Guidance for the preparation of dossiers for sensory additives (EFSA FEEDAP
Panel, 2012a), Technical Guidance for assessing the safety of feed additives for the environment
(EFSA, 2008b), Guidance for the preparation of dossiers for additives already authorised for use in
food (EFSA FEEDAP Panel, 2012b), Guidance for establishing the safety of additives for the consumer
(EFSA FEEDAP Panel, 2012c) and Guidance on studies concerning the safety of use of the additive for
users/workers (EFSA FEEDAP Panel, 2012d).
3. Assessment
3.1. Characterisation
3.1.1. Characterisation of the ﬂavouring additives
The molecular structures of the 22 additives under application are shown in Figure 1 and their
physicochemical characteristics in Table 1.
5 Commission Implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of ﬂavouring substances provided
for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to Regulation (EC)
No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 1565/2000 and
Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p. 1.
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
7 FEED dossier reference: FAD-2010-0053.
8 The full report is available on the EURL website https://ec.europa.eu/jrc/sites/default/files/FinRep-FAD-2010-0053.pdf
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2,3-Diethylpyrazine 
[14.005]
2-Ethyl-3-methylpyrazine 
[14.006]
5,6,7,8-Tetrahydro 
quinoxaline [14.015]
2,3,5,6-Tetramethyl 
pyrazine [14.018]
2,3,5-Trimethylpyrazine 
[14.019]
2,5-Dimethylpyrazine 
[14.020]
2,6-Dimethylpyrazine 
[14.021]
2-Ethylpyrazine [14.022]
2-Ethyl-3,5-dimethyl 
pyrazine [14.024]
2,5 or 6-Methoxy-3-methylpyrazine [14.025] 2-Methylpyrazine 
[14.027]
5-Methylquinoxaline 
[14.028]
Acetylpyrazine [14.032] 6,7-Dihydro-5-methyl-5H-
cyclopenta(b)pyrazine(a)
[14.037]
2-Isobutyl-3-methoxy 
pyrazine [14.043]
2-Acetyl-3-ethylpyrazine 
[14.049]
2,3-Dimethylpyrazine 
[14.050]
2,3-Diethyl-5-
methylpyrazine(b) [14.056]
2-(sec-Butyl)-3-
methoxypyrazine 
[14.062]
3,(5- or 6-)-Dimethyl-2-ethyl-pyrazine(c) [14.100] 2-Ethyl-3-methoxypyrazine 
[14.112]
2-Methoxy-3-
methylpyrazine [14.126]
(a): In the technical dossier, the compound is identiﬁed as 5H-5-methyl-6,7-dihydrocyclopenta(b)
pyrazine.
(b): In the technical dossier, the compound is identiﬁed as diethyl-5-methylpyrazine.
(c): In the technical dossier, the compound is identiﬁed as 2-ethyl-3,(5 or 6)dimethylpyrazine.
Figure 1: Molecular structures and [FLAVIS numbers] of the 22 ﬂavouring compounds under
assessment
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These substances are produced by chemical synthesis. Several routes of synthesis are available and
described in the dossier.9
Batch-to-batch variation data were provided for ﬁve batches of each additive with the exception of
2,3-diethylpyrazine (one batch available due to the low use volume), 2-ethylpyrazine and 2-acetyl-3-
ethylpyrazine (three batches), diethyl-5-methyl pyrazine and 2-(sec-butyl)-3-methoxypyrazine (four
batches).10 The content of the active substance for all compounds exceeded the JECFA speciﬁcations
(Table 2).
Table 1: Chemical Abstracts Service (CAS) and FLAVIS numbers and some characteristics of the 22
ﬂavouring compounds under assessment
EU Register name CAS No FLAVIS No
Molecular
formula
Molecular
weight
Physical
state
Log
Kow
(a)
2,3-Diethylpyrazine 15707-24-1 14.005 C8H12N2 136.2 Liquid 1.51
2-Ethyl-3-methylpyrazine 15707-23-0 14.006 C7H10N2 122.17 Liquid 1.07
5,6,7,8-Tetrahydroquinoxaline 34413-35-9 14.015 C8H10N2 134.18 Solid 1.41
2,3,5,6-Tetramethylpyrazine 1124-11-4 14.018 C8H12N2 136.2 Solid 1.82
2,3,5-Trimethylpyrazine 14667-55-1 14.019 C7H10N2 122.17 Liquid 0.95
2,5-Dimethylpyrazine 123-32-0 14.020 C6H8N2 108.14 Liquid 0.63
2,6-Dimethylpyrazine 108-50-9 14.021 C6H8N2 108.14 Solid 0.54
2-Ethylpyrazine 13925-00-3 14.022 C6H8N2 108.14 Liquid 0.69
2-Ethyl-3,5-dimethylpyrazine 13925-07-0(b) 14.024 C8H12N2 136.2 Liquid 1.63
2,5- or 6-Methoxy-3-
methylpyrazine(c)
63450-30-6 14.025 C6H8ON2 124.14 Liquid 0.28
2-Methylpyrazine 109-08-0 14.027 C5H6N2 94.12 Liquid 0.21
5-Methylquinoxaline 13708-12-8 14.028 C9H8N2 144.18 Liquid 2.04
Acetylpyrazine 22047-25-2 14.032 C6H6ON2 122.13 Solid 0.2
6,7-Dihydro-5-methyl-5H-
cyclopenta(b)pyrazine
23747-48-0 14.037 C8H10N2 134.18 Liquid 1.83
2-Isobutyl-3-methoxypyrazine 24683-00-9 14.043 C9H14ON2 166.22 Liquid 2.86
2-Acetyl-3-ethylpyrazine 32974-92-8 14.049 C8H10ON2 150.18 Liquid 1.15
2,3-Dimethylpyrazine 5910-89-4 14.050 C6H8N2 108.14 Liquid 0.54
2,3-Diethyl-5-methylpyrazine 18138-04-0 14.056 C9H14N2 150.22 Liquid 1.95
2-(sec-Butyl)-3-methoxypyrazine 24168-70-5 14.062 C9H14ON2 166.22 Liquid 1.92
3,(5- or 6-)-Dimethyl-2-
ethylpyrazine(d)
27043-05-6 14.100 C8H12N2 136.2 Liquid 2.07*
2-Ethyl-3-methoxypyrazine 25680-58-4 14.112 C7H10N2O 132.14 Liquid 1.80
2-Methoxy-3-methylpyrazine 2847-30-5 14.126 C6H8N2O 124.14 Liquid 1.24
EU: European Union; CAS No: Chemical Abstract Service number.; FLAVIS number: EU Flavour Information System number.
(a): Logarithm of octanol–water partition coefﬁcient.
(b): Three CAS numbers have been used to identify 2-ethyldimethylpyrazine, two refer to 2-ethyl-3,5-dimethylpyrazine (CAS Nos
13925-07-0 and 55031-15-7) and one to mixture of isomers 2-ethyl-3,(5 or 6)-dimethylpyrazine (CAS No 27043-05-6). They
are all relevant to the assessment of this compound.
(c): Mixture of three positional methoxy-isomers: 2-methoxy-3-methylpyrazine (75–85%); 2-methoxy-5-methylpyrazine (15–25%)
and 2-methoxy-6-methylpyrazine (1–2%) (sum 97%). The CAS number applies to all three isomers. Different CAS numbers
are associated to individual isomers: 2-methoxy-3-methylpyrazine (CAS No 2847-30-5), 2-methoxy-5-methylpyrazine (CAS No
2882-22-6) and 5-methoxy-3-methylpyrazine (CAS No 2882-21-5).
(d): The additive is a mixture of the two isomers. The CAS number applies to the mixture. A different CAS number (55031-15-7)
reported in the dossier refers to 2-ethyl-3,5-dimethylpyrazine. See also (2).
*: Generated from Epi-Suite 4.01.
9 Technical dossier/Section II.
10 Technical dossier/Section II/Annex 2.1 and Supplementary information June 2011.
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Potential contaminants are considered as part of the product speciﬁcation and are monitored as
part of the Hazard Analysis and Critical Control Point procedure applied by all consortium members.
The parameters considered include residual solvents, heavy metals and other undesirable substances.
However, no evidence of compliance was provided for these parameters.
3.1.2. Stability
The shelf-life for the compounds under assessment is at least 24 months when stored in closed
containers under recommended conditions. This assessment is made on the basis of compliance with
the original speciﬁcation over this storage period.
3.1.3. Conditions of use
The applicant proposes the use of all of the 22 additives in feed for all animal species without
withdrawal. For all 22 additives, the applicant proposes a normal use level of 0.1 mg/kg feed and a
high use level of 0.5 mg/kg.
3.2. Safety
The assessment of safety is based on the highest use level proposed by the applicant (0.5 mg/kg
complete feed).
Table 2: Identity of the substances and data on purity
EU Register name FLAVIS No
JECFA speciﬁcation
minimum %(a)
Assay %
Average Range
2,3-Diethylpyrazine 14.005 > 97 99.2(b) –
2-Ethyl-3-methylpyrazine 14.006 > 97* 99.9 99.5–100
5,6,7,8-Tetrahydroquinoxaline 14.015 > 98 99.3 99.0–99.7
2,3,5,6-Tetramethylpyrazine 14.018 > 95 99.7 98.5–100
2,3,5-Trimethylpyrazine 14.019 > 98 99.6 98.2–100
2,5-Dimethylpyrazine 14.020 > 98* 99.6 99.2–99.9
2,6-Dimethylpyrazine 14.021 > 98* 99.7 99.4–100
2-Ethylpyrazine 14.022 > 98 99.4 99.3–99.6
2-Ethyl-3,5-dimethylpyrazine 14.024 > 95 99.9 99.6–100
2,5 or 6-Methoxy-3-methylpyrazine 14.025 > 97* 100.0 99.9–100
2-Methylpyrazine 14.027 > 98 99.8 99.6–100
5-Methylquinoxaline 14.028 > 98 100.0 99.9–100
Acetylpyrazine 14.032 > 99 99.9 99.8–100
6,7-Dihydro-5-methyl-5H-cyclopenta(b)
pyrazine
14.037 > 97 98.4 98.3–98.8
2-Isobutyl-3-methoxypyrazine 14.043 > 95 99.8 99.6–100
2-Acetyl-3-ethylpyrazine 14.049 > 98 99.8 99.6–100
2,3-Dimethylpyrazine 14.050 > 95* 99.8 99.6–100
2,3-Diethyl-5-methylpyrazine 14.056 > 98 99.6 99.4–99.6
2-(sec-Butyl)-3-methoxypyrazine 14.062 > 99 99.6 99.0–100
3,(5- or 6-)-Dimethyl-2-ethylpyrazine 14.100 > 95 99.9* 99.9–100
2-Ethyl-3-methoxypyrazine 14.112 > 99 99.8 99.5–99.9
2-Methoxy-3-methylpyrazine 14.126 > 97 99.3(c) 97.4–100
FLAVIS number: EU Flavour Information System number.
(a): FAO, 2006.
(b): One batch, use of the product 1 kg/year or less.
(c): Speciﬁcations reﬂect commercial product.
*: Sum of isomers.
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3.2.1. Absorption, distribution, metabolism and excretion (ADME)
Compounds belonging to CG 24 are absorbed from the gastrointestinal tract and share common
pathways of metabolism: (i) oxidation of the side-chain(s) of alkyl-, alicyclic- and alkylaryl substituted
pyrazine derivatives, (ii) oxidation of methylpyrazines to the corresponding pyrazine-2-carboxylic acids
(iii) hydroxylation of the pyrazine ring, (iv) reduction of the ketone functional group of acylated pyrazines
to the corresponding secondary alcohol and (v) conjugation of products of oxidative metabolism with
glycine, glucuronic acid or sulfate, and glucuronidation of secondary alcohols (WHO, 2002a,b, FAS 48).
Metabolic studies of pyrazine derivatives mainly performed in the rat after oral administration showed
that rats dosed individually with a number of compounds under assessment have an efﬁcient excretion
mechanism for pyrazine derivatives at 100 mg/kg body weight (bw). About 90% of 2-methylpyrazine,
2,5-dimethylpyrazine and 2,6-dimethylpyrazine were excreted within 24 h as the corresponding pyrazine-
2-carboxylic acid derivative. This acid was mainly eliminated unconjugated, with 10–15% excreted as
a glycine conjugate. For 2,3-dimethylpyrazine, due to the steric hindrance of the methyl groups, only
10–15% was oxidised to 2-methylpyrazine-3-carboxylic acid. 2,3-Dimethyl-5-hydroxypyrazine is the main
metabolite, attaining about 40% of the administered dose and eliminated as a conjugate. Also in rats,
2-isobutyl-3-methoxypyrazine was eliminated in urine mainly as the conjugate of the O-demethylated
metabolite. A minor metabolite 2-methoxy-3-(2-carboxypropyl)pyrazine was also identiﬁed resulting from
the oxidation of the aliphatic side-chain (Hawksworth and Scheline, 1975).
Studies of metabolism of pyrazine derivatives in animals other than rodents are lacking in the
scientiﬁc literature. However, the enzymes involved in the biotransformation pathways of these
compounds are present in all target species. Alkyl groups of pyrazine derivatives are oxidised mainly by
P450 type enzymes to form the corresponding alcohols or carboxylic acids; the ring is hydroxylated by
molybdenum-containing oxidases of the xanthine oxidase type (M€uller and Rappert, 2010). The CYP450
monooxygenase families are present and have been characterised in a number of food-producing
animals, including ruminants, horses, pigs, (Nebbia et al., 2003; Ioannides, 2006; Fink-Gremmels, 2008),
ﬁsh (Wolf and Wolfe, 2005) and birds (Blevins et al., 2012). The molybdenum hydroxylases are also
present in several animal species (Morikawa et al., 1997; Hainline and Rajagopalan, 2013). Cytosolic
carbonyl reductases that reduce ketones to secondary alcohols were characterised in the liver and kidney
of several animal species, namely chicken, rabbit and sheep, as reviewed by Felsted and Bachur (1980).
Thus, it is expected that the acyl-pyrazine derivatives can be reduced and subsequently conjugated for
excretion. Phase II conjugation via glucuronidation, sulfation or addition of glycine has been reported to
occur in mammals although the predominance of one pathway over another varies among animal
species (Gupta, 2007). All target species, also carry out conjugation reactions with sulfate and glucuronic
acid (Watkins and Klaassen, 1986; James, 1987; Gusson et al., 2006), producing water-soluble
derivatives that are eliminated in urine. The FEEDAP Panel notes that for feline species the capacity for
conjugation is limited (Court, 2013).
3.2.2. Toxicological studies
Subchronic, repeated-dose studies, with multiple doses tested could not be found for any of the
compounds under assessment.
Summaries of toxicological data on single dose level studies are available for 2,3-diethylpyrazine
[14.005], 2-ethyl-3-methylpyrazine [14.006], 2-ethyl-3,5-dimethylpyrazine [14.024], 2,5 or 6-methoxy-3-
methylpyrazine [14.025] and 5-methylquinoxaline [14.028] (Posternak et al., 1969), and acetylpyrazine
[14.032] (Posternak et al., 1975). Secondary references referred to repeated dose toxicity studies (90
days, one dose tested) in rat performed with 5,6,7,8-tetrahydroquinoxaline [14.015] (Oser, 1970),
2,3,5,6-tetramethylpyrazine [14.018] (Oser, 1969a), 2,3,5-trimethylpyrazine [14.019] (Oser, 1969b), 2,6-
dimethylpyrazine [14.021], (Oser, 1969d), 3,(5- or 6-)-dimethyl-2-ethylpyrazine [14.100] (Oser, 1969c)
and 6,7-dihydro-5-methyl-5H-cyclopenta(b)pyrazine [14.037] (Wheldon and Krajkeman, 1967). Study
reports for these compounds are not available and the FEEDAP Panel is unable to conﬁrm the no
observed adverse effect levels (NOAELs) derived.
3.2.3. Safety for the target species
The ﬁrst approach to the safety assessment for target species takes account of the applied use
levels in animal feed relative to the maximum reported exposure of humans on the basis of the
metabolic body weight. The data for human exposure in the EU (EFSA CEF Panel, 2011a,b) ranges
from 0.1 to 100 lg/person per day, corresponding to 0.005 to 4.6 lg/kg0.75 per day. Table 3
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summarises the result of the comparison with human exposure for representative target animals. The
body weight of target animals is taken from the default values shown in Table 4.
Table 3 shows that for all compounds the intake by the target animals exceeds that of humans
resulting from use in food. As a consequence, safety for the target species at the feed concentration
applied cannot be derived from the risk assessment for food use.
As an alternative, the maximum feed concentration considered as safe for the target animal can be
derived from the lowest NOAEL available. However, adequate subchronic, repeated-dose studies
performed with the additives under assessment were not available. Therefore, the threshold of
toxicological concern (TTC) approach was followed to derive the maximum safe feed concentration
(EFSA FEEDAP Panel, 2012a).
All compounds except 5-methylquinoxaline belong to the Cramer Class II. The calculated safe use
level for these compounds is 0.5 mg/kg complete feed for cattle, salmonids and non-food-producing
animals, and 0.3 mg/kg complete feed for pigs and poultry. 5-Methylquinoxaline (Cramer Class III) is
safe at 0.0 mg/kg complete feed for cattle, salmonids and non-food-producing animals, and 0.05 mg/kg
complete feed for pigs and poultry.
Table 3: Comparison of exposure of humans and target animals to the ﬂavourings under application
EU Register name
Use level in feed
(mg/kg)
Human exposure
(lg/kg bw0.75 per day)(a)
Target animal exposure
(lg/kg bw0.75 per day)
Salmon Piglet
Dairy
cow
2,3-Diethylpyrazine 0.5 0.07 11.8 52.6 77.7
2-Ethyl-3-methylpyrazine 0.5 3.34 11.8 52.6 77.7
5,6,7,8-Tetrahydroquinoxaline 0.5 0.37 11.8 52.6 77.7
2,3,5,6-Tetramethylpyrazine 0.5 0.31 11.8 52.6 77.7
2,3,5-Trimethylpyrazine 0.5 4.46 11.8 52.6 77.7
2,5-Dimethylpyrazine 0.5 0.88 11.8 52.6 77.7
2,6-Dimethylpyrazine 0.5 0.06 11.8 52.6 77.7
2-Ethylpyrazine 0.5 0.10 11.8 52.6 77.7
2-Ethyl-3,5-dimethylpyrazine 0.5 0.06 11.8 52.6 77.7
2,5 or 6-Methoxy-3-
methylpyrazine
0.5 0.70(b) 11.8 52.6 77.7
2-Methylpyrazine 0.5 0.79 11.8 52.6 77.7
5-Methylquinoxaline 0.5 1.02 11.8 52.6 77.7
Acetylpyrazine 0.5 0.56 11.8 52.6 77.7
6,7-Dihydro-5-methyl-5H-
cyclopenta(b)pyrazine
0.5 0.18 11.8 52.6 77.7
2-Isobutyl-3-methoxypyrazine 0.5 4.92 11.8 52.6 77.7
2-Acetyl-3-ethylpyrazine 0.5 0.03 11.8 52.6 77.7
2,3-Dimethylpyrazine 0.5 0.65 11.8 52.6 77.7
Diethyl-5-methylpyrazine 0.5 0.05 11.8 52.6 77.7
2-(sec-Butyl)-3-
methoxypyrazine
0.5 0.04 11.8 52.6 77.7
3,(5- or 6-)-Dimethyl-2-
ethylpyrazine
0.5 1.76 11.8 52.6 77.7
2-Ethyl-3-methoxypyrazine 0.5 0.05(b) 11.8 52.6 77.7
2-Methoxy-3-methylpyrazine 0.5 0.70 11.8 52.6 77.7
bw: body weight.
(a): Metabolic body weight (kg bw0.75) for a 60-kg person = 21.6.
(b): EU ﬁgures not available (exposure based on US intake ﬁgures).
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3.2.3.1. Conclusions on safety for the target species
The FEEDAP Panel concludes that:
• 2,3-diethylpyrazine [14.005], 2-ethyl-3-methylpyrazine [14.006], 5,6,7,8-tetrahydroquinoxaline
[14.015], 2,3,5,6-tetramethylpyrazine [14.018], 2,3,5-trimethylpyrazine [14.019], 2,5-dimethylpyrazine
[14.020], 2,6-dimethylpyrazine [14.021], 2-ethylpyrazine [14.022], 2-ethyl-3,5-dimethylpyrazine [14.024],
2,5 or 6-methoxy-3-methylpyrazine [14.025], 2-methylpyrazine [14.027], acetylpyrazine [14.032],
6,7-dihydro-5-methyl-5H-cyclopenta(b)pyrazine [14.037], 2-isobutyl-3-methoxypyrazine [14.043], 2-
acetyl-3-ethylpyrazine [14.049], 2,3-dimethylpyrazine [14.050], 2,3-diethyl-5-methylpyrazine [14.056],
2-(sec-butyl)-3-methoxypyrazine [14.062], 3,(5- or 6-)-dimethyl-2-ethylpyrazine [14.100], 2-ethyl-3-
methoxypyrazine [14.112] and 2-methoxy-3-methylpyrazine [14.126] are safe at the proposed
maximum dose level (0.5 mg/kg complete feed) for cattle, salmonids and non-food-producing animals,
and at the proposed normal use level of 0.1 mg/kg complete feed for pigs and poultry;
• 5-methylquinoxaline [14.028] is safe only at concentrations below the proposed use levels
(0.08 mg/kg complete feed for cattle, salmonids and non-food-producing animals, and
0.05 mg/kg complete feed for pigs and poultry).
3.2.4. Safety for the consumer
The safety for the consumer of the compounds in CG 24, used as food ﬂavours, has already been
assessed by JECFA (WHO, 2002a,b) and EFSA (EFSA 2008a, EFSA CEF Panel, 2011a). All these
compounds are presently authorised as food ﬂavourings without limitations.5
Given the proposed use levels of CG 24 compounds to be applied in feed, the expected metabolism
and excretion in target animals (see Section 3.2.1), the FEEDAP Panel considers that the possible
residues in food derived from animals fed with these ﬂavourings would not appreciably increase the
human intake levels of these compounds. Consequently, no safety concern would arise for the
consumer from the use of these 22 compounds up to the highest safe level in feeds.
3.2.5. Safety for the user
No speciﬁc data on the safety for the user were provided. In the material safety data sheets,11
hazards for skin and eye contact and respiratory exposure are recognised for the majority of the
compounds under application. Most are classiﬁed as irritating to the respiratory system.
3.2.6. Safety for the environment
The additions of naturally occurring substances that will not result in a substantial increase in the
concentration in the environment are exempt from further assessment. Examination of the published
literature shows that this applies to 14 substances, namely 2-ethyl-3-methylpyrazine [14.006], 2,3,5,6-
tetramethylpyrazine [14.018], 2,3,5-trimethylpyrazine [14.019], 2,5-dimethylpyrazine [14.020], 2,6-
dimethylpyrazine [14.021], 2-ethylpyrazine [14.022], 2-ethyl-3,5-dimethylpyrazine [14.024], 2,5 or
6-methoxy-3-methylpyrazine [14.025], 2-methylpyrazine [14.027], acetylpyrazine [14.032], 6,7-
dihydro-5-methyl-5H-cyclopenta(b)pyrazine [14.037], 2-isobutyl-3-methoxypyrazine [14.043], 2,3-
dimethylpyrazine [14.050] and 3,(5- or 6-)-dimethyl-2-ethylpyrazine [14.100], which occur in the
environment at levels above the application rate of 0.5 mg/kg feed (data taken from the Netherlands
Organisation for Applied Scientiﬁc Research (TNO) database Volatile Compounds in Food ver. 14.1;
Burdock, 2003).12
The other eight compounds, namely 2,3-diethylpyrazine [14.005], 5,6,7,8-tetrahydroquinoxaline
[14.015], 5-methylquinoxaline [14.028], 2-acetyl-3-ethylpyrazine [14.049], 2,3-diethyl-5-methylpyrazine
[14.056], 2-(sec-butyl)-3-methoxypyrazine [14.062], 2-ethyl-3-methoxypyrazine [14.112] and 2-
methoxy-3-methylpyrazine [14.126], could not be shown to occur in the environment at levels above the
application rate of 0.5 mg/kg feed. For these compounds, the predicted environmental concentration for
soil (PECsoil) was calculated based on the use rate (Table 4) and compared with the trigger values for
compartments set in the phase I of the EFSA guidance on environmental risk assessment for feed
additives (EFSA, 2008b).
11 Technical dossier/Section II/Annex II.3.
12 Technical dossier/Supplementary information June 2011.
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The PECsoil values are above the threshold of 10 lg/kg (EFSA, 2008b). The PEC for pore water
(PECporewater) is dependent on the sorption, which is different for each compound. For these
calculations, the substance-dependent constants organic carbon sorption constant (Koc), molecular
weight, vapour pressure and solubility are needed. These were estimated from the Simpliﬁed Molecular
Input Line Entry Speciﬁcation (SMILES) notation of the chemical structure using EPIWEB 4.1
(Table 5).13 This program was also used to derive the SMILES notation from the CAS numbers. The Koc
value derived from the ﬁrst-order molecular connectivity index was used, as recommended by the
EPIWEB program.
The half-life (DT50) was calculated using BioWin4.1 (Ultimate Survey Model), which gives a rating
number. This rating number r was translated into a half-life using the formula by Arnot et al. (2005):
DT50 ¼ 10ðr1:07þ4:12Þ
This is the general regression used to derive estimates of aerobic environmental biodegradation
half-lives from BioWin4.1 model output.
Table 4: Predicted environmental concentration (PEC) values of the eight ﬂavourings of CG 24
under assessment (calculated for lamb manure)
EU Register name CAS No
Dose
mg/kg
PECsoil
(lg/kg)
PECporewater
(lg/L)
PECsurfacewater
(lg/L)
2,3-Diethylpyrazine 15707-24-1 0.5 10.7 15.5 5.2
5,6,7,8-Tetrahydroquinoxaline 34413-35-9 0.5 10.7 1.5 0.5
5-Methylquinoxaline 13708-12-8 0.5 10.7 5.2 1.7
2-Acetyl-3-ethylpyrazine 32974-92-8 0.5 10.7 12.7 4.2
2,3-Diethyl-5-methylpyrazine 18138-04-0 0.5 10.7 6.3 2.1
2-(sec-Butyl)-3-methoxypyrazine 24168-70-5 0.5 10.7 2.7 0.9
2-Ethyl-3-methoxypyrazine 25680-58-4 0.5 10.7 8.7 2.9
2-Methoxy-3-methylpyrazine 2847-30-5 0.5 10.7 25.1 8.4
EU: European Union; CAS No: Chemical Abstracts Service number; PEC: predicted environmental concentration.
Table 5: Physicochemical properties predicted by EPIWEB 4.1 for the eight ﬂavourings of CG 24
under assessment
EU Register name CAS No.
Predicted by EPIWEB 4.1
DT50
(a)
(days)
Molecular
weight (g/mol)
Vapour
pressure (Pa)
Solubility
(mg/L)
Koc
(b)
(L/kg)
2,3-Diethylpyrazine 15707-24-1 15 136.20 103.0 4,458 32.4
5,6,7,8-
Tetrahydroquinoxaline
34413-35-9 15 134.20 12.4 2,091 391
5-Methylquinoxaline 13708-12-8 13 144.18 0.7 1,456 110
2-Acetyl-3-ethylpyrazine 32974-92-8 14 150.18 2.2 20,720 41
2,3-Diethyl-5-
methylpyrazine
18138-04-0 20 150.23 73.1 1,636 89
2-(sec-Butyl)-3-
methoxypyrazine
24168-70-5 17 166.22 4.7 230 220
2-Ethyl-3-
methoxypyrazine
25680-58-4 15 138.17 23.2 2,474 63
2-Methoxy-3-
methylpyrazine
2847-30-5 14 124.14 77.9 8,457 17
EU: European Union; CAS No: Chemical Abstracts Service number.
(a): DT50, half-life of the additive (EPIWB 4.1.BioWin4.1).
(b): Koc, organic carbon sorption constant (EPIWB 4.1.KocWin2.0).
13 Available online: http://www.epa.gov/opptintr/exposure/pubs/episuitedl.htm
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For the eight substances, the calculated predicted concentrations for groundwater (PECporewater)
are above 0.1 lg/L and for soil (PECsoil) above 10 lg/kg (Table 4). Therefore, they are subject to
phase II risk assessment.
In the absence of experimental data, the phase II risk assessment was performed using ECOSAR
v1.11, which estimates the half-maximal effective concentration (EC50) or lethal concentration (LC50)
for earthworms, ﬁsh, green algae and daphnids from the SMILES notation of the substance. The
predicted no effect concentration (PNEC) for terrestrial environment (PNECsoil) was determined by
dividing the LC50 earthworm by an uncertainty factor (UF) of 1,000. The corresponding PNEC for
aquatic compartment (PNECaquatic) was derived from the lowest toxicity value for freshwater
environment by applying an UF of 1,000.
For all eight compounds, the ratio PEC/PNEC for soil and surface water was < 1 (Table 6),
indicating that there is no risk for the terrestrial and fresh water compartments at the maximum
proposed use level of 0.5 mg/kg.
If used in ﬁsh feed at the highest proposed use level of 0.5 mg/kg complete feed in land-based
aquaculture systems, none of all additives under assessment would result in a predicted environmental
concentration of the additive (parent compound) in surface water (PECswaq) above the trigger value of
0.1 lg/L when calculated according to the guidance (EFSA, 2008b). For sea cages, a dietary
concentration of 0.047 mg/kg would ensure that the threshold for the predicted environmental
concentration of the additive (parent compound) in sediment (PECsed) of 10 lg/kg is not exceeded
when calculated according to the EFSA guidance (EFSA, 2008b).
Table 6: Phase II environmental risk assessment of soil and aquatic compartments for CG 24
compounds used as feed additives for terrestrial farm animals (exposure and effect data
were modelled using EPIWEB 4.1 and ECOSAR 1.11)
EU Register name
Soil
LC50
(a) Earthworm
(mg/kg)
PNECsoil
(lg/kg)
PECsoil
(lg/kg)
PECsoil
/PNECsoil
2,3-Diethylpyrazine 236 236 10.7 0.05
5,6,7,8-Tetrahydroquinoxaline 238 238 10.7 0.04
5-Methylquinoxaline 272 272 10.7 0.04
2-Acetyl-3-ethylpyrazine 360 360 10.7 0.03
2,3-Diethyl-5-methylpyrazine 228 228 10.7 0.05
2-(sec-Butyl)-3-methoxypyrazine 235 235 10.7 0.05
2-Ethyl-3-methoxypyrazine 243 243 10.7 0.04
2-Methoxy-3-methylpyrazine 245 245 10.7 0.04
Aquatic
LC50
Fish
(mg/L)
LC50
Daphnids
(mg/L)
EC50
(b)
Algae
(mg/L)
PNECaquatic
(lg/L)
PECsw
(c)
(lg/L)
PECsw/
PNECsw
2,3-Diethylpyrazine 108 61 46 46 5.2 0.11
5,6,7,8-Tetrahydroquinoxaline 134 75 54 54 0.5 0.01
5-Methylquinoxaline 238 131 86 86 1.7 0.02
2-Acetyl-3-ethylpyrazine 1,974 990 442 442 4.2 0.01
2,3-Diethyl-5-methylpyrazine 38 23 21 21 2.1 0.10
2-(sec-Butyl)-3-methoxypyrazine 23 14 15 14 0.9 0.06
2-Ethyl-3-methoxypyrazine 125 70 52 52 2.9 0.06
2-Methoxy-3-methylpyrazine 309 167 101 101 8.4 0.08
EU: European Union; PNECsoil: predicted no effect concentration for terrestrial environment; PECsoil: predicted environmental
concentration for soil; PNECaquatic: predicted no effect concentration for aquatic compartment.
(a): LC50: the concentration of a test substance which results in a 50% mortality of the test species.
(b): EC50: the concentration of a test substance which results in 50% of the test animals being adversely affected (i.e. both
mortality and sublethal effects).
(c): PECsw: Predicted environmental concentration in surface water.
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3.2.6.1. Conclusions on safety for the environment
The maximum proposed use level of 0.5 mg/kg is unlikely to have detrimental effects on the
terrestrial and fresh water compartments for any of the compounds under application. For the marine
environment, the safe use level is estimated to be 0.05 mg/kg feed.
3.3. Efﬁcacy
Since all 22 compounds are used in food as ﬂavourings, and their function in feed is essentially the
same as that in food no further demonstration of efﬁcacy is necessary.
4. Conclusions
The FEEDAP Panel concludes that 2,3-diethylpyrazine [14.005], 2-ethyl-3-methylpyrazine [14.006],
5,6,7,8-tetrahydroquinoxaline [14.015], 2,3,5,6-tetramethylpyrazine [14.018], 2,3,5-trimethylpyrazine
[14.019], 2,5-dimethylpyrazine [14.020], 2,6-dimethylpyrazine [14.021], 2-ethylpyrazine [14.022], 2-
ethyl-3,5-dimethylpyrazine [14.024], 2,5 or 6-methoxy-3-methylpyrazine [14.025], 2-methylpyrazine
[14.027], acetylpyrazine [14.032], 6,7-dihydro-5-methyl-5H-cyclopenta(b)pyrazine [14.037], 2-isobutyl-
3-methoxypyrazine [14.043], 2-acetyl-3-ethylpyrazine [14.049], 2,3-dimethylpyrazine [14.050], 2,
3-diethyl-5-methylpyrazine [14.056], 2-(sec-butyl)-3-methoxypyrazine [14.062], 3,(5- or 6-)-dimethyl-
2-ethylpyrazine [14.100], 2-ethyl-3-methoxypyrazine [14.112] and 2-methoxy-3-methylpyrazine
[14.126] are safe at the proposed maximum dose level (0.5 mg/kg complete feed) as feed for cattle,
salmonids and non-food-producing animals, and at the proposed normal use level of 0.1 mg/kg
complete feed for pigs and poultry; 5-methylquinoxaline [14.028] is safe only at concentrations below
the proposed use levels (0.08 mg/kg complete feed for cattle, salmonids and non-food-producing
animals, and 0.05 mg/kg complete feed for pigs and poultry).
No safety concern would arise for the consumer from the use of these compounds up to the
highest proposed level in feeds.
Hazards for skin and eye contact and respiratory exposure are recognised for the majority of the
compounds under application. Most are classiﬁed as irritating to the respiratory system.
The maximum proposed use level of 0.5 mg/kg is unlikely to have detrimental effects on the
terrestrial and fresh water compartments for any of the compounds under application.
Because all the compounds under assessment are used in food as ﬂavourings and their function in
feed is essentially the same as that in food, no further demonstration of efﬁcacy is necessary.
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Abbreviations
ADI acceptable daily intake
ADME absorption, distribution, metabolism and excretion
bw body weight
CAS Chemical Abstracts Service
CD Commission Decision
CDG chemically deﬁned group
CEF EFSA Scientiﬁc Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids
CG chemical group
DM dry matter
DT50 degradation half-time
EC50 half-maximal effective concentration
ECOSAR component program of EPI suiteTM
EEIG European Economic Interest Grouping
EPI suite Estimation Programs Interface (EPI) SuiteTM
EURL European Union Reference Laboratory
FAO Food and Agriculture Organization
FEEDAP EFSA Scientiﬁc Panel on Additives and Products or Substances used in Animal Feed
FFAC Feed Flavourings authorisation Consortium of (FEFANA) the EU Association of Specialty
Feed Ingredients and their Mixtures
FGE Flavouring Group Evaluation
FLAVIS the EU Flavour Information System
FL-No FLAVIS number
GC–MS gas chromatography–mass spectrometry
JECFA The Joint FAO/WHO Expert Committee on Food Additives
Koc organic carbon sorption constant
Kow octanol–water partition coefﬁcient
LC50 lethal concentration 50
Log Kow logarithm of octanol–water partition coefﬁcient
NOAEL no observed adverse effect level
PEC predicted environmental concentration
PECsed predicted environmental concentration of the additive (parent compound)
in sediment
PECporewater predicted environmental concentration for porewater
PECsoil predicted environmental concentration for soil
PECsurfacewater predicted environmental concentration for surface water
PECswaq predicted environmental concentration of the additive (parent compound)
in surface water
PNEC predicted no environmental concentration
PNECsoil predicted no environmental concentration for terrestrial environment
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PNECaquatic predicted no environmental concentration for aquatic compartment
RTL retention time locking
SMILES Simpliﬁed Molecular Input Line Entry Speciﬁcation
TNO Netherlands Organisation for Applied Scientiﬁc Research
TTC threshold of toxicological concern
UF uncertainty factor
WHO World Health Organization
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Chemically deﬁned ﬂavourings from Chemical group
24 – Pyrazine derivatives
The Chemically Deﬁned Flavourings - Group 24 (Pyrazine derivatives), in this application comprises
22 substances, for which authorisation as feed additives is sought under the category “sensory
additives”, functional group 2(b) “ﬂavouring compounds”, according to the classiﬁcation system of
Annex I of Regulation (EC) No 1831/2003.
In the current application submitted according to Article 4(1) and Article 10 (2) of Regulation (EC)
No 1831/2003, the authorisation for all species and categories is requested. The ﬂavouring compounds
of interest have a purity ranging from 95% to 99%.
Mixtures of ﬂavouring compounds are intended to be incorporated only into feedingstuffs or
drinking water. The Applicant suggested no minimum or maximum levels for the different ﬂavouring
compounds in feedingstuffs.
For the identiﬁcation of volatile chemically deﬁned ﬂavouring compounds CDG24 in the feed
additive, the Applicant submitted a qualitative multi-analyte gas-chromatography mass-spectrometry
(GC-MS) method, using Retention Time Locking (RTL), which allows a close match of retention times
on GC-MS. By making an adjustment to the inlet pressure, the retention times can be closely matched
to those of a reference chromatogram. It is then possible to screen samples for the presence of target
compounds using a mass spectral database of RTL spectra. The Applicant maintained two FLAVOR2
databases/libraries (for retention times and for MS spectra) containing data for more than 409
ﬂavouring compounds. These libraries were provided to the CRL. The Applicant provided the typical
chromatogram for the CDG24 of interest.
In order to demonstrate the transferability of the proposed analytical method (relevant for the
method veriﬁcation), the Applicant prepared a model mixture of ﬂavouring compounds on a solid
carrier to be identiﬁed by two independent expert laboratories. This mixture contained twenty
chemically deﬁned ﬂavourings belonging to twenty different chemical groups to represent the whole
spectrum of compounds in use as feed ﬂavourings with respect to their volatility and polarity. Both
laboratories properly identiﬁed all the ﬂavouring compounds in all the formulations. Since the
substances of CDG24 are within the volatility and polarity range of the model mixture tested, the
Applicant concluded that the proposed analytical method is suitable to determine qualitatively the
presence of the substances from CDG24 in the mixture of ﬂavouring compounds.
Based on the satisfactory experimental evidence provided, the CRL recommends for ofﬁcial control
for the qualitative identiﬁcation in the feed additive of the individual (or mixture of) ﬂavouring
compounds of interest the GC-MS-RTL (Agilent speciﬁc) method submitted by the Applicant.
As no experimental data were provided by the Applicant for the identiﬁcation of the active
substance(s) in feedingstuffs and water, no methods could be evaluated. Therefore the CRL is unable
to recommend a method for the ofﬁcial control to identify the active substance(s) of interest in
feedingstuffs or water.
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